Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
June 09 2006 - 5:05PM
PR Newswire (US)
SAN DIEGO, June 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the Goldman Sachs Global
Healthcare Conference on Wednesday, June 14, 2006 at 9:20 a.m. PT
in Laguna Nigel, CA. Mark G. Foletta, Senior Vice President,
Finance and Chief Financial Officer of Amylin Pharmaceuticals, will
be providing a corporate overview. The live presentation will be
webcast, and a recording will be made available following the
event. The webcast and recording will be accessible through
Amylin's corporate website, located at http://www.amylin.com/. To
access the live webcast, please log on to Amylin's site
approximately fifteen minutes prior to the presentation to register
and download any necessary audio software. About Amylin
Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical
company committed to improving lives through the discovery,
development and commercialization of innovative medicines. Amylin
has developed and gained approval for two first-in-class medicines
for diabetes, SYMLIN(R) (pramlintide acetate) injection and
BYETTA(R) (exenatide) injection. Amylin's research and development
activities leverage the company's expertise in metabolism to
develop promising therapies to treat diabetes, obesity and
cardiovascular disease. Amylin is located in San Diego, California
with over 1200 employees nationwide. Further information on Amylin
Pharmaceuticals is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024